LRRK2 Polypeptidesubstrate und ihre Verwendungen

Patent europeic · EP2199405 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2199405
Numer da la dumonda
EP09252042
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
24-08-2009
Publitgà
23-06-2010
Concedì
07-03-2012
Stritgà
31-08-2013
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/48 (2006.01)
C07K 4/00 (2006.01)
C12N 15/00 (2006.01)
G01N 33/68 (2006.01)
Prioritad
GB 0817106 18.09.2008
US 244715 02.10.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-03-2014

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.03.2014

  2. 08-03-2012

    Represchentant inscrit

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 324, 1226 Geneve-Thônex

    Published in Swissreg on 08.03.2012

  3. 07-03-2012

    Concedì

    Published in Swissreg on 07.03.2012

Partidas

Possessur

Medical Research Council

2nd Floor, David Phillips Building Polaris House North Star Avenue,, Swindon Wiltshire, SN2 1FL, GB

Represchentant

Kirker & Cie SA

Kirker & Cie S.A.

122, rue de Genève Case postale 324, 1226 Geneve-Thônex

Inventur

Alessi, Dario

Dundee DD1 5EH, GB

Nichols, R. Jeremy

Dundee DD1 5EH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.